PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Coating the surface of nanoparticles with polyethylene glycol (PEG), or “PEGylation”, is a commonly used approach for improving the efficiency of drug and gene delivery to target cells and tissues. Building from the success of PEGylating proteins to improve systemic circulation time and decrease imm...

Full description

Saved in:
Bibliographic Details
Published in:Advanced drug delivery reviews 2016-04, Vol.99 (Pt A), p.28-51
Main Authors: Suk, Jung Soo, Xu, Qingguo, Kim, Namho, Hanes, Justin, Ensign, Laura M.
Format: Article
Language:English
Subjects:
Animals
Drug Delivery Systems
Enhanced permeability and retention (EPR) effect
Gene Transfer Techniques
Humans
Liposomes
Mononuclear phagocyte system (MPS)
Mucosal delivery
Nanoparticles - administration & dosage
Nanoparticles - chemistry
Polyethylene Glycols - administration & dosage
Polyethylene Glycols - chemistry
Stealth coatings
Surface Properties
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coating the surface of nanoparticles with polyethylene glycol (PEG), or “PEGylation”, is a commonly used approach for improving the efficiency of drug and gene delivery to target cells and tissues. Building from the success of PEGylating proteins to improve systemic circulation time and decrease immunogenicity, the impact of PEG coatings on the fate of systemically administered nanoparticle formulations has, and continues to be, widely studied. PEG coatings on nanoparticles shield the surface from aggregation, opsonization, and phagocytosis, prolonging systemic circulation time. Here, we briefly describe the history of the development of PEGylated nanoparticle formulations for systemic administration, including how factors such as PEG molecular weight, PEG surface density, nanoparticle core properties, and repeated administration impact circulation time. A less frequently discussed topic, we then describe how PEG coatings on nanoparticles have also been utilized for overcoming various biological barriers to efficient drug and gene delivery associated with other modes of administration, ranging from gastrointestinal to ocular. Finally, we describe both methods for PEGylating nanoparticles and methods for characterizing PEG surface density, a key factor in the effectiveness of the PEG surface coating for improving drug and gene delivery. [Display omitted]
ISSN:0169-409X
1872-8294
DOI:10.1016/j.addr.2015.09.012